Skip to main content

Table 1 Quality assessment of included clinical studies

From: The role of tumor-infiltrating lymphocytes in cholangiocarcinoma

Ref

Author

Selection

Comparability

Outcomes

Quality score

[17]

Asahi Y

★★★★

★

★

6/9

[18]

Goeppert B

★★★★

★

★★

7/9

[19]

Hasita H

★★★★

★★

★★

8/9

[20]

Kim HD

★★★

★★

★

6/9

[21]

Kim R

★★★

★★

★★

7/9

[22]

Kitano Y

★★★★

★★

★★

8/9

[23]

Lu JC

★★★★

★★

★

7/9

[24]

Miura T

★★★★

★★

★★

9/9

[25]

Oshikiri T

★★★★

★★

★

7/9

[26]

Tian L

★★★★

★★

★★★

9/9

[27]

Ueno T

★★★★

★★

★★★

9/9

[28]

Vigano L

★★★

★★

★★

7/9

[29]

Wu H

★★★★

★★

★★

8/9

[30]

Xu YP

★★★★

★★

★★

8/9

  1. All included translational studies reporting oncological outcome were evaluated in accordance with the Newcastle-Ottawa scale [16]. The maximum score of the scale is nine points with studies being categorized as low (0-3 points), moderate (4-6 points) and high quality (7-9 points), respectively